StockGlow

Hikal Limited (HIKAL.NS)

Makes chemical ingredients for medicines, pesticides, and industrial products

221.38+0.02%Healthcare
Compare HIKAL.NS with
StockGlow Score
84
Bullish
BearishBullish
1 year ago-30.2%

The outlook

HIKAL.NS is trading above both its 50- and 200-day moving averages, positioning it in the upper half of its 52-week range. The single analyst covering the stock rates it a Strong Buy with an average price target about 36% above the current level. The overall data tilt appears constructive, though coverage is thin.

What’s behind the score

Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendAbove its 50- & 200-day averages
52-week range41% of the way from its 52-week low to high
Price targetAvg target +36% vs current price
Market cap
$27.30B
52-wk high
331.05
52-wk low
146.25
50-day avg
211.18
200-day avg
207.64
Trailing P/E
—

Similar stocks

INDOCO.NSIndoco Remedies Limited$225.05-1.32%FDC.NSFDC Limited$414.30+1.68%AARTIDRUGS.NSAarti Drugs Limited$411.25+0.72%JBCHEPHARM.NSJ. B. Chemicals & Pharmaceuticals Limited$2,416.10+0.30%GRANULES.NSGranules India Limited$841.85-0.42%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy